title: [Statin intolerance].
abstract: In 2015, more than 530 000 people were prescribed statins in Norway. Adverse effects from the musculoskeletal system as well as less specific side effects are frequently reported. The extent of these contrasts with observations made in randomised controlled studies which report the prevalence of such adverse effects as being in line with placebo. Breaks from drug treatment, low doses, switching medication and use of other lipid-lowering drugs are the most relevant approaches to dealing with adverse effects.
authors.affiliation: Seksjon for preventiv kardiologi Avdeling for endokrinologi, sykelig overvekt og forebyggende medisin Oslo universitetssykehus.
authors.forename: Serena
authors.initials: S
authors.lastname: Tonstad
mesh_terms: D001688:Biological Products / Q000008:administration & dosage / Q000627:therapeutic use; D000069438:Ezetimibe / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D000091362:PCSK9 Inhibitors; D012307:Risk Factors; D000071449:Proprotein Convertase 9
chemical_list: D001688:Biological Products; D000069438:Ezetimibe; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D000091362:PCSK9 Inhibitors; C117343:red yeast rice; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9